Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Youn, Clover E.; * | Lu, Christine | Cauchi, Jonathan | MacGowan, Daniel | Morgenstern, Rachelle | Scelsa, Stephen
Affiliations: Icahn School of Medicine at Mount Sinai Downtown, Department of Neurology, New York, New York, USA
Correspondence: [*] Correspondence to: Clover E. Youn DO, Department of Neurology, University of Washington Medical Center, 1959 NE Pacific St, 8th floor, Seattle, WA 98195, USA. Tel.: +1 206 353 8217; E-mail: ceyoun@uw.edu.
Note: [1] Department of Neurology, University of Washington Medical Center, 1959 NE Pacific St, 8th floor, Seattle, WA 98195, USA
Note: [2] Kaiser Permanente, 2500 Merced Street, San Leandro, CA 94577, USA
Note: [3] Department of Neurology, University of New Mexico, 2211 Lomas Blvd NE, Albuquerque, NM, USA
Abstract: Introduction:Though eye movements are relatively spared in motor neuron disease (MND), recent literature suggests patients may exhibit oculomotor dysfunction (OD). Frontal lobe involvement has been postulated based on oculomotor pathway anatomy and clinical overlap of amyotrophic lateral sclerosis (ALS) with frontotemporal dementia. We examined oculomotor characteristics in patients with MND presenting to an ALS Center, hypothesizing that patients with prominent upper motor neuron involvement or pseudobulbar affect (PBA) may demonstrate greater OD. Methods:This was a single-center prospective observational study. Patients with diagnosis of MND were examined at bedside. Center for Neurologic Study-Liability Scale (CNS-LS) was administered to screen for pseudobulbar affect. Primary outcome was OD and the secondary outcome was the association between presence of OD in patients with MND experiencing symptoms of PBA or upper motor neuron dysfunction. Wilcoxon rank-sum scores and Fisher’s exact tests were used to perform statistical analyses. Results:53 patients with MND underwent the clinical ophthalmic evaluation. On bedside examination, 34 patients (64.2%) presented with OD. There were no significant associations between locations of MND at presentation and the presence or type of OD. OD was associated with increased disease severity as measured by reduced FVC (p = 0.02). There was no significant association between OD and CNS-LS (p = 0.2). Discussion:Though our study did not find a significant association between OD and upper versus lower MND at presentation, OD may be useful as an additional clinical marker for advanced disease.
Keywords: Motor neuron disease, amyotrophic lateral sclerosis, eye movement data analysis, ophthalmoplegia
DOI: 10.3233/JND-221579
Journal: Journal of Neuromuscular Diseases, vol. 10, no. 3, pp. 405-410, 2023
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl